 News
November 8, 2019,
Preclinapps attends BioFIT 2019 conference in Marseille, France on 10-11 Decembe...
|
 |
|
MedRod速 implants Registered trademark developed by Preclinapps
MedRod速 delivers active ingredient in efficient and reliable manner to support and improve the quality of preclinical studies. It is stable and cost-effective substitute to chronic injections. What is MedRod速
- Long-term drug release from a week to years
- Estrogens, androgens and other small molecules
- Dose range from 10 ng/day up to 200 mcg/day
- Elastic and biocompatible soft matrix
- Each batch and dosage validated unlike competing long-term drug delivery systems
|  | Do you know the release rate of your drug delivery system? Is it based on assumption or real measurements? When generating hormone dependent PDX, xenograft or syngeneic tumor studies it is vital to know exact release rate of hormones to avoid adverse effects and to promote optimal tumor growth.
| |
Updated
14 November, 2019
| | |
|
